Mongolia vs Switzerland: Cause of death, by non-communicable diseases, ages 60+
Mongolia
83.0%
in 2021
Switzerland
82.8%
in 2021
Mongolia rank
32nd
Switzerland rank
34th
Cause of death, by non-communicable diseases, ages 60+ over time
- Mongolia
- Switzerland
How they compare
Mongolia currently reports 83.0% against 82.8% in Switzerland, a difference of 0.2%.
Across all 6 years both countries report, Mongolia has been ahead every year.
Mongolia ranks 32nd and Switzerland ranks 34th of 185 countries.
Mongolia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Mongolia | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 95.4% | 91.0% | 4.4% | Mongolia |
| 2010s | 95.9% | 91.6% | 4.4% | Mongolia |
| 2020s | 89.6% | 80.8% | 8.8% | Mongolia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, Mongolia or Switzerland?
- Mongolia, at 83.0% against 82.8% in Switzerland as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+ between Mongolia and Switzerland?
- 0.2%, with Mongolia ahead.
- How many years of comparable data are there for Mongolia and Switzerland?
- 6 years are reported by both, from 2000 to 2021.
- How do Mongolia and Switzerland rank globally for cause of death, by non-communicable diseases, ages 60+?
- Mongolia ranks 32nd and Switzerland ranks 34th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+ (% of total deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 60+ due to non-communicable diseases divided by number of all deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.